Neuropsychiatric disorders: investigation of schizophrenia and substance abuse (Q35532407)

8 August 2017

1 reference

title

Neuropsychiatric disorders: investigation of schizophrenia and substance abuse (English)

1 reference

emission computed tomography

8 August 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1439871

26 September 2022

author name string

N. D. Volkow

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1439871

26 September 2022

J. S. Fowler

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1439871

26 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1439871

26 September 2022

publication date

1 October 1992

1 reference

Seminars in Nuclear Medicine

8 August 2017

1 reference

8 August 2017

22

1 reference

8 August 2017

254-267

1 reference

8 August 2017

4

1 reference

Developments in the drug treatment of schizophrenia

8 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Low frontal glucose utilization in chronic schizophrenia: a replication study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Brain organization in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Regional Brain Function in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Characteristics of very poor outcome schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Positron emission tomography in schizophrenic patients with and without neuroleptic medication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Long-term frontal brain metabolic changes in cocaine abusers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Intercorrelations of glucose metabolic rates between brain regions: application to healthy males in a state of reduced sensory input.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Brain interactions in chronic schizophrenics under resting and activation conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Striatal metabolic rate and clinical response to neuroleptics in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Limbic/mesolimbic connections and the pathogenesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Cortico-striate projections in the rhesus monkey: The organization of certain cortico-caudate connections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Mesocorticolimbic dopaminergic network: functional and regulatory roles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

New insights into the pathophysiology of Parkinson's disease: the challenge of positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Increased temporal lobe glucose use in chronic schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Low cerebellar metabolism in medicated patients with chronic schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Three subtypes of chronic schizophrenia identified using 11C-glucose positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Drugs, neurotransmitters, and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

The significance of dopamine for the mode of action of neuroleptics and the pathogenesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Bimodal Distribution of Dopamine Receptor Densities in Brains of Schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

No D2 receptor increase in PET study of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Positron emission tomography (PET) studies of dopaminergic/cholinergic interactions in the baboon brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Plasma level monitoring of antipsychotic drugs. Clinical utility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

In vivo assay for neuroleptic receptor binding in the striatum. Positron tomography in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Dopamine receptor occupancy and plasma haloperidol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Mapping cocaine binding sites in human and baboon brain in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Direct actions of cocaine on cardiac cellular electrical activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Cerebral blood flow in chronic cocaine users: a study with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Subarachnoid hemorrhage precipitated by cocaine snorting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Changes in brain glucose metabolism in cocaine dependence and withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

New concepts in cocaine addiction: the dopamine depletion hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Effects of chronic cocaine abuse on postsynaptic dopamine receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

A Study of Alcoholism in Half Siblings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Neurobiology of alcohol abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Local cerebral glucose utilisation in chronic alcoholics: a positron tomographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Alteration of regional cerebral glucose metabolic rate in non-Korsakoff chronic alcoholism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

PET determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using 11C-glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Acute effects of ethanol on regional brain glucose metabolism and transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

Ethanol and the benzodiazepine-GABA receptor-ionophore complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980120-5

10.1016/S0001-2998(05)80120-5

7 January 2021

Identifiers

DOI

1 reference

8 August 2017

1 reference